Kotecha, Ritesh R. http://orcid.org/0000-0002-0223-3479
Motzer, Robert J. http://orcid.org/0000-0001-6925-2327
Voss, Martin H. http://orcid.org/0000-0003-0551-5807
Article History
First Online: 16 April 2019
Change Date: 25 April 2019
Change Type: Correction
Change Details: The competing interests section of the HTML and PDF versions of this manuscript originally did not include the research support received by Robert J. Motzer from Eisai. This information has been added to the competing interests section of the HTML and PDF versions of the manuscript.
Competing interests
: R.R.K. declares no competing interests. R.J.M. has received research support from Bristol-Myers Squibb, Eisai, Genentech, Novartis and Pfizer and honoraria for advisory and consulting roles from Genentech, Incyte, Merck, Novartis and Pfizer. M.H.V. has received research support from Bristol-Myers Squibb, Genentech, Novartis and Roche, travel and accommodation support from Eisai, Novartis and Takeda and has been a paid consultant for Alexion, Bayer, Calithera, Corvus, Eisai, Exelixis, GlaxoSmithKline, Natera, Novartis and Pfizer.